Director of Hematology [27/01/2010] |
|
PURPOSE:
Within Medical Affairs, Biopharmaceuticals, this Director functions as a medical advisor for NNI and key external customers to further scientific exchange. Incumbent provides product and field scientific support to Medical, Sales and Marketing, as well as Managed Care and Government by using academic credentials and scientific expertise to communicate with health care providers and organizations. The Director will also provide leadership and direction for the conduct and reporting of ongoing local Phase IIIb/IV clinical trials and registries. The Director will provide support to Medical Information, Marketing and Regulatory Departments as needed and will be responsible for overseeing the publication of data and review articles in the hemostasis therapeutic area. The Director will also play a major role in the establishment and function of expert advisory panels in the areas of hemostasis and hemophilia.
RELATIONSHIPS:
Position reports to the Executive Director, Hemostasis. Additional key internal relationships are with the regional medical liaisons and directors, research clinicians and clinical project managers, marketing, MCT&G, and Sales personnel. External relationships include key opinion leaders (KOL’s), academic institutions, managed care organizations, physicians, nurse practitioners, and pharmacists.
ESSENTIAL FUNCTIONS:
CLINICAL SUPPORT
•Provides leadership for scientific support activities and supports Field personnel as needed.
•Works with the Executive Director, the Director Medical Affairs, the Director, Marketing and the Product Manager(s) to identify scientific needs and research opportunities and implements tactics to support scientific and business needs in the U.S.
•Scientific support for marketed products and development projects focusing on NovoSeven® in the hemophilia/congenital bleeding disorder area.
•Collaborates with Marketing, MCT&G and Sales management to develop scientific strategies to optimize NNI’s products and development activities in the medical community.
•With Executive Director, Director Medical Affairs oversight, conduct needs assessment for therapeutics in healthcare, the risks of intervention and the potential market for intervention.
•Support the drug information unit, by providing timely review of materials developed for communication with customers, as well as responding to inquiries where specific professional expertise in hemostasis/hemophilia clinical science is required.
•Maintain a thorough working knowledge of NNI, its products, current scientific research and publications associated with same. Provide medical review for hemophilia related promotional materials.
CONDUCT OF CLINICAL TRIALS
•Write, review, and/or approve and ensure quality Phase IIIb and Phase IV clinical trial protocols.
•Helps to support and analyze clinical trial and registry data relating to Phase IIIb/IV studies and the HTRS registry.
•Serve as an advisor to clinical research teams for projects in early stage development.
•Ensure timely publication of clinical trial results.
•Assist in the development of timelines, and budgets, relevant to the management of ongoing local trials and registries.
•Provide regional medical input on the global clinical development plans related to hemophilia.
•Obtain expert medical community input as required to design high quality studies.
•Identify academic centers and investigators to initiate and/or participate in clinical trials and identify key areas of future research.
COORDINATION OF EDUCATIONAL PROGRAMS
•Assist with training of field personnel on product knowledge and use of technical information in selling situations.
ADVOCACY DEVELOPMENT
•Identify, contact, develop and maintain relations with health care providers to establish and/or support the use of NNI products; when necessary, assist in resolving issues pertaining to that use.
•Responsible for establishing and coordinating the scientific activities of consultant and advisory boards.
INSURANCE REIMBURSEMENT & COVERAGE PROJECTS
•Design, develop, and deliver scientific presentations to individuals and groups of strategic importance to NNI.
ADMINISTRATIVE DUTIES
Provide monthly (or more frequent, when required) report on all activities to Executive Director, including budget expenditures
DEVELOPMENT OF PEOPLE:
•Ensure that reporting personnel have 3P forms with annual goals and measurements that are consistent with the priorities of the business, and that interim reviews are held so that their work is focused on those priorities, and they understand their level of accountability for results and the measurement process.
•Manage the application and communication of all Novo Nordisk policies, procedures, and Novo Nordisk Way of Management.
•Ensure that the IDP forms include completed Learning and Aspiration plans and are in place for all reporting personnel to enable the achievement of goals and capability to assume increased levels of responsibility.
KEY SUCCESS FACTORS: EDUCATION, EXPERIENCE, KNOWLEDGE AND SKILLS
•M.D. degree with completed residency program required, preferably in hematology, critical care or related field.
•At least 5 years experience in a pharmaceutical company, medical affairs experience preferred, hemostasis, hemophilia, blood clotting disorders experience strongly preferred
•Clinical trial experience desirable.
OTHER:
•Works within Novo Nordisk’s established policies and procedures and ensures alignment of their work to Novo Nordisk fundamentals.
•Embraces Novo Nordisk Values in spirit and actions.
•Approximately 30-40% overnight travel.
Job Type:
Permanent
Location:
Montana-Helena/Butte
Salary:
[n/a]
Date available:
now
Experience Skills:
Director
Company:
Novo Nordisk
Company Description:
Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy.
Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 29,000 employees in 81 countries, and markets its products in 179 countries.
Novo Nordisks B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol NVO.
Company Website:
[n/a]
In order to apply for this job, please click on the Apply button
|
 
|
08/12/2009